People channel feed – Endpoints News

People channel feed

Under siege, investment manager Woodford faces another investment shock

6 years ago

Turns out, Rudy Tanzi didn't see much of a story about a hidden link between Enbrel and Alzheimer's either

6 years ago

J&J gains an enthusiastic endorsement from President Donald Trump for their big new drug Spravato

6 years ago

Roche catapults Thomas Schinecker to chief of diagnostics unit

6 years ago

Sanofi recruits Novartis' top pharma exec Paul Hudson as its new CEO — so what happens now?

6 years ago

Ex-Juno chief Hans Bishop takes the helm at cancer testing startup Grail in a shakeup as IPO rumors percolate

6 years ago

Clock starts ticking on Leif Johansson's retirement from AstraZeneca chairman role — report

6 years ago

Ned Sharpless weighs in on gene therapy pricing debate, suggesting 'the messaging got lost'

6 years ago

Bristol-Myers bumps off chief scientist in another big shakeup, bringing in Celgene and Novartis execs

6 years ago

Neil Woodford forcefully stems investor outflow by suspending his beleaguered main fund

6 years ago

Add one fatal flaw to Jiankui He's litany of mistakes in CRISPR baby debacle

6 years ago

Maligned ex-MiMedx chief Petit wants back on the board — wound care company tells shareholders to say no way

6 years ago

Shkreli settles into his new prison digs in Pennsylvania with a $30M+ lawsuit against former Retrophin colleagues

6 years ago

Ned Sharpless slammed with critical letter from a key Democratic Senator unhappy with e-cig policies

6 years ago

After a short stay in the biotech world, Dietmar Berger is back in Big Pharma R&D — and he's taking a prominent place in Sanofi

6 years ago

New Gilead chief O’Day axes worldwide ops chief and recruits Bristol-Myers’ Johanna Mercier for the top team

6 years ago

Atara brings on Novartis vet to replace founder Ciechanover as chief

6 years ago

Project Snow White: Internal probe reveals former MiMedx C-suite spied on employees, lied to regulators and misled investors

6 years ago

Sobered by mounting costs, Dynavax looks to unload I/O, slash jobs and circle wagons around Heplisav

6 years ago

Ex-FDA commish Scott Gottlieb makes a quick jump back onto the money side of biotech

6 years ago

Dana-Farber’s 4-year legal battle shines a light on the origins of PD-1 research — forcing a reckoning on who pioneered the landmark cancer breakthrough

6 years ago

As Daiichi Sankyo-partnered breast cancer drug marches toward finish line, AstraZeneca brings in Canadian scientist Sunil Verma to rev up R&D

6 years ago

Tillman Gerngross isn't out to impress you with biobucks, but here are 3 partner deals that should

7 years ago

Brent Saunders has a message for Allergan investors today: He feels your pain

7 years ago

First page Previous page 77 78 798081 82 83 Next page Last page